10 states are diabetes 'hot spots'
The states of California, Florida, Georgia, Illinois, Michigan, New York, North Carolina, Ohio, Pennsylvania and Texas have the dubious distinction of being "diabetes hot spots," where the burden of diabetes will be greatest in the next 15 years, according to a report by the Institute for Alternative Futures (IAF).
The IAF report sought to discover how the growing diabetes epidemic will spread geographically in the U.S. and how this might affect local economies.
The IAF diabetes assessment model was based on available national diabetes data including recent Centers for Disease Prevention and Control projections and population projections. It assumes a steady, but conservative, reduction in the number of people with complications due to better awareness of the risks of diabetes, earlier screening and intervention, as well as more effective therapies.
The IAF model estimated that the overall number of people in the U.S. living with diabetes will increase 64 percent by 2025, from 32.3 million today to 53.1 million--which equates to one in seven Americans. The resulting medical and societal cost of diabetes will be almost $514 billion, a 72 percent increase from 2010, according to the Washington, D.C.-based IAF.
The 10 diabetes hot-spot states now shoulder nearly 60 percent of the cost from diabetes, or approximately $176 billion of the total $299 billion, IAF stated. In 15 years, the cost of diabetes to these 10 states is projected to jump to $297 billion, the institute added.
The breakdown of Americans with diabetes in 2025 within the 10 states, and the cost to each state, are predicted to be as follows:
The researchers projected that these 10 states will carry half the population burden of diabetes in the U.S., with more than 50 percent of Americans with diabetes living in these areas.
The report was commissioned and funded by Novo Nordisk.
The IAF report sought to discover how the growing diabetes epidemic will spread geographically in the U.S. and how this might affect local economies.
The IAF diabetes assessment model was based on available national diabetes data including recent Centers for Disease Prevention and Control projections and population projections. It assumes a steady, but conservative, reduction in the number of people with complications due to better awareness of the risks of diabetes, earlier screening and intervention, as well as more effective therapies.
The IAF model estimated that the overall number of people in the U.S. living with diabetes will increase 64 percent by 2025, from 32.3 million today to 53.1 million--which equates to one in seven Americans. The resulting medical and societal cost of diabetes will be almost $514 billion, a 72 percent increase from 2010, according to the Washington, D.C.-based IAF.
The 10 diabetes hot-spot states now shoulder nearly 60 percent of the cost from diabetes, or approximately $176 billion of the total $299 billion, IAF stated. In 15 years, the cost of diabetes to these 10 states is projected to jump to $297 billion, the institute added.
The breakdown of Americans with diabetes in 2025 within the 10 states, and the cost to each state, are predicted to be as follows:
- California: Projected cost of $63.63 billion, 6.6 million people with diabetes;
- Texas: Projected cost of $52.17 billion, 5.5 million people with diabetes;
- Florida: Projected cost of $40.43 billion, 4.2 million people with diabetes;
- New York: Projected cost of $28.38 billion, 2.9 million people with diabetes;
- Ohio: Projected cost of $19.76 billion, 2.1 million people with diabetes;
- Illinois: Projected cost of $19.67 billion, 2 million people with diabetes;
- Georgia: Projected cost of $19.54 billion, 2 million people with diabetes;
- Pennsylvania: Projected cost of $18.37 billion, 1.9 million people with diabetes;
- North Carolina: Projected cost of $17.91 billion, 1.9 million people with diabetes; and
- Michigan: Projected cost of $15.85 billion, 1.6 million people with diabetes.
The researchers projected that these 10 states will carry half the population burden of diabetes in the U.S., with more than 50 percent of Americans with diabetes living in these areas.
The report was commissioned and funded by Novo Nordisk.